Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer.
Jiabing WangHaoqian XuYing WangLong FengFengming YiPublished in: Canadian journal of gastroenterology & hepatology (2023)
DEB-TACE has a promising effect in the treatment of primary or secondary liver cancer. The treatment-related adverse reactions are tolerable.